LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 2,760 -14.00 (-0.50%) As of 11:52 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Bioventix Stock (LON:BVXP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bioventix alerts:Sign Up Key Stats Today's Range 2,721▼ 2,80050-Day Range 2,600▼ 3,02052-Week Range 2,200▼ 4,545Volume794 shsAverage Volume7,620 shsMarket Capitalization£144.52 millionP/E Ratio17.85Dividend Yield5.72%Price TargetN/AConsensus RatingN/A Company Overview Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read More Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Email Address BVXP Stock News HeadlinesDo Its Financials Have Any Role To Play In Driving Bioventix PLC's (LON:BVXP) Stock Up Recently?June 1, 2025 | finance.yahoo.comShareholders in Bioventix (LON:BVXP) are in the red if they invested a year agoMay 6, 2025 | finance.yahoo.comI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.July 14 at 2:00 AM | Porter & Company (Ad)5 AIM stocks to consider buying for the long termApril 24, 2025 | msn.com3 UK Dividend Stocks Offering Yields Up To 7.2%April 8, 2025 | finance.yahoo.com3 top AIM stocks to consider buying before they recoverMarch 19, 2025 | uk.finance.yahoo.comWith 62% ownership, Bioventix PLC (LON:BVXP) boasts of strong institutional backingFebruary 9, 2025 | finance.yahoo.comWill the stock market rise in 2025, and how high could it go?December 14, 2024 | msn.comSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 3,240 at the beginning of 2025. Since then, BVXP shares have decreased by 14.8% and is now trading at GBX 2,760. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) announced its quarterly earnings results on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share for the quarter. Bioventix had a trailing twelve-month return on equity of 69.09% and a net margin of 59.51%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON). Company Calendar Last Earnings3/31/2025Record date for 4/25 Dividend4/10/2025Ex-Dividend for 4/25 Dividend4/10/2025Dividend Payable4/25/2025Today7/14/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 154.62 Trailing P/E Ratio17.79 Forward P/E Ratio16.54 P/E GrowthN/ANet Income£8.12 million Net Margins59.51% Pretax MarginN/A Return on Equity69.09% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio7.42 Quick Ratio5.50 Sales & Book Value Annual Sales£13.65 million Price / Sales10.55 Cash FlowGBX 89.03 per share Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / Book11.96Miscellaneous Outstanding Shares5,236,318Free FloatN/AMarket Cap£144.00 million OptionableNot Optionable Beta0.35 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (LON:BVXP) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.